Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)

被引：0
作者：
Guanggai Xia
Hongcheng Wang
Ziliang Song
Qingcai Meng
Xiuyan Huang
Xinyu Huang
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of general surgery
[2] Fudan University Shanghai Cancer Center,Department of Pancreatic Surgery, Pancreatic Cancer Institute
来源：
Journal of Experimental & Clinical Cancer Research | / 36卷
关键词：
Pancreatic cancer; Gemcitabine; Gambogic acid; RRM2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 33 条
[21]   Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone [J].
Liu, XY ;
Zhou, BS ;
Xue, LJ ;
Qiu, WH ;
Shih, J ;
Zheng, S ;
Yen, Y .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (08) :1499-1511
[22]   Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway [J].
Shan, Jinlan ;
Wang, Zhen ;
Mo, Qiuping ;
Long, Jingpei ;
Fan, Yangfan ;
Cheng, Lu ;
Zhang, Tao ;
Liu, Xiyong ;
Wang, Xiaochen .
PANCREATOLOGY, 2022, 22 (03) :401-413
[23]   Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine [J].
Souglakos, J. ;
Boukovinas, I. ;
Taron, M. ;
Mendez, P. ;
Mavroudis, D. ;
Tripaki, M. ;
Hatzidaki, D. ;
Koutsopoulos, A. ;
Stathopoulos, E. ;
Georgoulias, V. ;
Rosell, R. .
BRITISH JOURNAL OF CANCER, 2008, 98 (10) :1710-1715
[24]   Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine [J].
J Souglakos ;
I Boukovinas ;
M Taron ;
P Mendez ;
D Mavroudis ;
M Tripaki ;
D Hatzidaki ;
A Koutsopoulos ;
E Stathopoulos ;
V Georgoulias ;
R Rosell .
British Journal of Cancer, 2008, 98 :1710-1715
[25]   Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy [J].
Fisher, Sarah B. ;
Fisher, Kevin E. ;
Patel, Sameer H. ;
Lim, Matthew G. ;
Kooby, David A. ;
El-Rayes, Bassel F. ;
Staley, Charles A., III ;
Adsay, N. Volkan ;
Farris, Alton B., III ;
Maithel, Shishir K. .
CANCER, 2013, 119 (02) :454-462
[26]   Small Interfering RNA (siRNA)-Mediated Silencing of the M2 Subunit of Ribonucleotide Reductase A Novel Therapeutic Strategy in Ovarian Cancer [J].
Zhang, Meng ;
Wang, Jing ;
Yao, RuYong ;
Wang, LiMing .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (04) :659-666
[27]   The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC) [J].
Lee, Jae Jin ;
Maeng, Chi Hoon ;
Baek, Seon Kyung ;
Kim, Gou Young ;
Yoo, Jee-Hong ;
Choi, Cheon Woong ;
Kim, Yee Hyung ;
Kwak, Young-Tae ;
Kim, Dae-Hyun ;
Lee, Young Kyung ;
Kim, Jung Bo ;
Kim, Si-Young .
LUNG CANCER, 2010, 70 (02) :205-210
[28]   pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression [J].
Wang, Min ;
Lu, Xingjiao ;
Dong, Xueguang ;
Hao, Fengyun ;
Liu, Zimin ;
Ni, Guangzhen ;
Chen, Dong .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
[29]   pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression [J].
Min Wang ;
Xingjiao Lu ;
Xueguang Dong ;
Fengyun Hao ;
Zimin Liu ;
Guangzhen Ni ;
Dong Chen .
World Journal of Surgical Oncology, 13
[30]   Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages [J].
Qiaofei Liu ;
Yuan Li ;
Zheyu Niu ;
Yi Zong ;
Mengyi Wang ;
Lutian Yao ;
Zhaohui Lu ;
Quan Liao ;
Yupei Zhao .
Journal of Experimental & Clinical Cancer Research, 35
1234